A MULTICENTER, OPEN-LABEL, PHASE 1/2, DOSE ESCALATION AND SUBSEQUENT SAFETY EXTENSION STUDY OF SUBCUTANEOUS KK8123 IN ADULT PATIENTS WITH X-LINKED HYPOPHOSPHATEMIA

Registry ID

8123-001

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

KYOWA KIRIN, INC.

Last update

2025-05-09

Conditions

• X-LINKED HYPOPHOSPHATEMIA

Related clinical trials

• A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY TO ASSESS THE EFFICACY AND SAFETY OF KRN23 VERSUS ORAL PHOSPHATE AND ACTIVE VITAMIN D TREATMENT IN PEDIATRIC PATIENTS WITH X LINKED HYPOPHOSPHATEMIA (XLH)

View on source registry